Induction of stable prenatal tolerance to β-galactosidase by in utero gene transfer into preimmune sheep fetuses

Blood

Volumn 97, Issue 11, 2001, Pages 3417-3423

  Tran, Nam D ^a,b,c   Porada, Christopher D ^a,b,c   Almeida Porada, Graça ^a,b,c   Glimp, Hudson A ^a,b,c   French Anderson, W ^a,b,c   Zanjani, Esmail D ^a,b,c  

^a VA Sierra Nevada Health Care System   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FETUS; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; THYMUS; TRANSGENE;

EID: 0035383766     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3417     Document Type: Article

References (54)

1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basil G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672.
2. Dunbar CE, Kohn DB, Schiffmann R, et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher's disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther. 1998;9:2629-2640.
3. Stewart AK, Sutherland DR, Nanji S, et al. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures. Hum Gene Ther. 1999;10:1953-1964.
4. Simonaro CM, Haskins ME, Abkowitz JL, et al. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation. Gene Ther. 1999;6:107-113.
5. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1995;10:1017-1023.
6. Kohn DB. Gene therapy for haematopoietic and lymphoid disorders. Clin Exp Immunol. 1997;107:54-57.
7. DeMatteo RP, Yeh H, Friscia M, et al. Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases. Ann Surg Oncol. 1999;6:88-94.
8. Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci U S A. 1998;95:11377-11382.
9. van Ginkel FW, McGhee JR, Liu C, et al. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J Immunol. 1997;159:685-693.
10. Liberatore C, Capanni M, Albi N, et al. Natural killer cell-mediated lysis of autologous cells modified by gene therapy. J Exp Med. 1999;189:1855-1862.
11. McCormack JE, Martineau D, DePolo N, et al. Anti-vector immunoglobulin induced by retroviral vectors. Hum Gene Ther. 1997;8:1263-1273.
12. Lutzko C, Kruth S, Abrams-Ogg ACG, et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine α-L-iduronidase deficiency. Blood. 1999;93:1895-1905.
13. Riddell SR, Elliott M, Lweinsohn DA, et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med. 1996;2:216-223.
14. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.
15. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood. 1999;94:2179-2191.
16. Zanjani ED, Anderson WF. Prospects for in utero gene therapy. Science. 1999;285:2084-2088.
17. Billingham R, Brent L, Medawar PB. Quantitative studies on tissue transplantation immunity. Philos Trans R Soc Lond Ser B Biol Sci. 1956;239:357-369.
18. Binns R. Bone marrow and lymphoid cell injection of the pig fetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature. 1969;214:179-181.
19. Porada CD, Tran N, Eglitis M, et al. In utero gene therapy: transfer and long-term expression of the bacterial Neo® gene in sheep following direct injection of retroviral vectors into pre-immune fetuses. Hum Gene Ther. 1998;9:1571-1585.
20. Tran ND, Porada CD, Zhao Y, Almeida-Porada G, Anderson WF, Zanjani ED. In utero transfer and expression of exogenous genes in sheep. Exp Hematol. 2000;28:17-30.
21. Mondino A, Khoruts A, Kenkins MK. The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A. 1996;93:2245-2252.
22. Sarzotti M. Immunologic tolerance. Curr Opin Hematol. 1997;4:48-52.
23. Gahery-Segard H, Molinier-Frenkel V, Le Boulaire C, et al. Phase I trial of recombinant adenovirus gene transfer in lung cancer longitudinal study of immune responses to transgene and viral products. J Clin Invest. 1997;100:2218-2226.
24. Braun J, Valentin H, Nugeyre MT, Ohayon H, Gounon P, Barre-Sinoussi F. Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1. Virology. 1996;225:413-418.
25. Woolley JA, Landon J. Comparison of antibody production to human interleukin-6 (IL-6) by sheep and chickens. J Immunol Methods. 1995;178:253-265.
26. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York, NY: John Wiley & Sons; 1994.
27. McCray PB, Armstrong K, Zabner J, et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest. 1995;95:2620-2632.
28. Vincent MC, Trapnell BC, Baughman RP, Wert SE, Whitsett JA, Iwamoto HS. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther. 1995;6:1019-1028.
29. Pitt BR, Schwartz MA, Pilewski JM, et al. Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther. 1995;2:344-350.
30. Iwamoto HS, Trapnell BC, McConnell CJ, Daugherty C, Whitsett JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther. 1999;6:98-106.
31. Themis M, Schneider H, Kiserud T, et al. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther. 1990;6:1239-1248.
32. Simon RH, Engelhardt JF, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther. 1993;4:771-780.
33. Zabner J, Petersen DM, Puga AP, et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet. 1994;6:75-83.
34. Lozier JN, Metzger ME, Donahue RE, Morgan RA. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood. 1999;94:3968-3975.
35. Herzog RW, Yang EY, Couto LB, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med. 1999;5:56-63.
36. Wang G, Williamson R, Mueller G, Thomas P, Davidson BL, McCray PB. Ultrasound-guided gene transfer to hepatocytes in utero. Fetal Diagn Ther. 1998;13:197-205.
37. Lukacs KV, Porter CD, Pardo OE, et al. In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice. Hum Gene Ther. 1999;10:2373-2379.
38. Izembart A, Aguado E, Gauthier O, Aubert D, Moullier P, Ferry N. In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response. Hum Gene Ther. 1999;10:2917-2925.
39. Rosenberg M, Kingma W, Fitzpatrick MA, Richards SM. Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration. Blood. 1999;93:2081-2088.
40. Lusher JM. Inhibitor antibodies to factor VIII and factor IX: management. Semin Thromb Hemost. 2000;26:179-188.
41. Marrack P, Lo D, Brinster R, et al. The effect of thymus environment on T cell development and tolerance. Cell. 1988;53:627-634.
42. Schwartz RH. Acquisition of immunologic selftolerance. Cell. 1989;57:1073-1081.
43. Adams TE. Tolerance to self-antigens in transgenic mice. Mol Biol Med. 1990;7:341-357.
44. Grossman Z, Paul WE. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin Immunol. 2000;12:197-203.
45. Sandberg JK, Franksson L, Sundback J, et al. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol. 2000;165:25-33.
46. Silverstein AM, Uhr JW, Kraner KL. Fetal response to antigenic stimulus II: antibody production by the fetal lamb. J Exp Med. 1963;117:799-812.
47. Silverstein AM, Prendergast RA, Kranner KL. Fetal response to antigenic stimulus IV: rejection of skin homograft by the fetal lamb. J Exp Med. 1964;119:955-964.
48. DeMatteo RP, Chu G, Ahn M, Chang E, Barker CF, Markmann JF. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol. 1997;71:5330-5335.
49. DeMatteo RP, Raper SE, Ahn M, et al. Gene transfer to the thymus: a means of abrogating the immune response to recombinant adenovirus. Ann Surg. 1995;222:229-239.
50. Ilan Y, Attavar P, Takahashi M, et al. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J Clin Invest. 1996;98:2640-2647.
51. Marshall DJ, Park BH, Korostoff JM, Gaulton GN. Manipulation of the immune response by foreign gene expression in the thymus. Leukemia. 1995;9(suppl 1):S128-S132.
52. Knechtle SJ, Wang J, Graeb C, et al. Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. J Immunol. 1997;159:152-158.
53. Lipshutz GS, Flebbe-Rehwaldt L, Gaensler KML. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther. 2000;4:374-380.
54. Porada CD, Tran ND, Zhao Y, Anderson WF, Zanjani ED. Neonatal gene therapy: transfer and expression of exogenous genes in neonatal sheep following direct injection of retroviral vectors into the bone marrow space. Exp Hematol. 2000;28:642-650.